Market Overview:
The global nasal drug delivery technology market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing demand for minimally invasive therapies, and technological advancements in nasal drug delivery devices. Based on type, the global nasal drug delivery technology market is segmented into pressurized type and non-pressurized type. The pressurized type segment is expected to account for a larger share of the market than the non-pressurized type segment during the forecast period. This can be attributed to factors such as ease of use and better patient compliance with pressurized devices compared with non-pressurized devices. Based on application, the global nasal drug delivery technology market is divided into nasal congestion, rhinitis, asthma, and other applications.
Product Definition:
Nasal drug delivery technology is a method of delivering medication to the nose for absorption into the bloodstream. This type of delivery is often used for medications that need to act quickly, such as rescue inhalers for asthma and allergies. The nasal passages are lined with tiny blood vessels that can quickly absorb medication, so it can be delivered directly to the lungs or brain. Nasal drug delivery technology is also used to deliver medications that need to be taken regularly, such as allergy medicine or birth control pills.
Pressurized Type:
Pressurized type nasal drug delivery system is a technology that involves the administration of drugs through nasal route. The most important factor contributing to its growth is increasing preference for non-invasive methods of drug delivery, which has resulted in reduced side effects and quicker recovery time. Additionally, it's cost-effectiveness as compared to other traditional routes such as oral or intravenous is also one of the factors responsible for pressurized type nasal drug delivery systems market growth over the forecast period.
Non-pressurized Type:
Non-pressurized type is also known as dry powder nasal drug delivery system. It is a non-invasive drug delivery technology that delivers drugs in the nose by using compressed air or nitrogen gas to blow the dose. This technology has been around for more than 50 years and was first used in 1960s for oral medications, such as vitamins and doxorubicin (Adriamycin).
Application Insights:
The other application segment includes nasal congestion, rhinitis, and asthma. The others segment dominated the market in 2017 owing to the increasing prevalence of allergic rhinitis and asthma. Nasal congestion was observed to be the most prevalent application as of 2017 due to its high treatment rate compared to other applications.
Pressurized-type devices are used for treating nasal congestion due largely in part to their ability pressure points around the nose and forehead thereby reducing swelling & pain caused by blockage or plugging of nose with fluid retention leading to discomfort & stress. Non-pressurized type devices are preferred for treating allergies since they have been proven more effective than pressurized types at a cheaper price point which is expected drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, technological advancements, and high demand for novel drug delivery systems. The U.S., which is at the forefront of this regional market, has a large number of chronic nasal diseases that require continuous treatment with anti-inflammatory and decongestant drugs thereby driving product adoption over the forecast period.
Asia Pacific is expected to register significant growth during the forecast period owing to rising disposable income levels.
Growth Factors:
- Increasing incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sinusitis is expected to drive the demand for nasal drug delivery technology over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to respiratory diseases.
- Technological advancements in nasal drug delivery devices such as development of novel drug-delivery platforms and introduction of smart inhalers are expected to propel the market growth over the forecast period.
- Rising awareness about benefits of using nasal drug delivery technology over traditional oral medication is projected to fuel market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nasal Drug Delivery Technology Market Research Report
By Type
Pressurized Type, Non-pressurized Type
By Application
Nasal Congestion, Rhinitis, Asthma, Other
By Companies
3M United States, Aegis Therapeutics LLC, Aptargroup, Inc., Becton, Dickinson and Company, BF Ascher & Company, Inc., Cadila Pharmaceuticals Ltd, Dickinson and Company, Douglas Pharmaceuticals Ltd, ENT Technologies Pty. Ltd, Glaxosmithkline PLC, 3M United States, Merck & Co., Inc., Novartis AG, OptiNose, Inc, PendoPharm, Inc, Pfizer, Inc, Promius Pharma, LLC, Shin Nippon Biomedical Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Nasal Drug Delivery Technology Market Report Segments:
The global Nasal Drug Delivery Technology market is segmented on the basis of:
Types
Pressurized Type, Non-pressurized Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nasal Congestion, Rhinitis, Asthma, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M United States
- Aegis Therapeutics LLC
- Aptargroup, Inc.
- Becton, Dickinson and Company
- BF Ascher & Company, Inc.
- Cadila Pharmaceuticals Ltd
- Dickinson and Company
- Douglas Pharmaceuticals Ltd
- ENT Technologies Pty. Ltd
- Glaxosmithkline PLC
- 3M United States
- Merck & Co., Inc.
- Novartis AG
- OptiNose, Inc
- PendoPharm, Inc
- Pfizer, Inc
- Promius Pharma, LLC
- Shin Nippon Biomedical Laboratories
Highlights of The Nasal Drug Delivery Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pressurized Type
- Non-pressurized Type
- By Application:
- Nasal Congestion
- Rhinitis
- Asthma
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nasal Drug Delivery Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nasal drug delivery technology is a method of delivering medications to the nose through the nasal passages. This delivery method is often used for medications that are not effective when taken by mouth, such as chemotherapy drugs. Nasal drug delivery technology can also be used to deliver other types of medication, such as vitamins and supplements.
Some of the major companies in the nasal drug delivery technology market are 3M United States, Aegis Therapeutics LLC, Aptargroup, Inc., Becton, Dickinson and Company, BF Ascher & Company, Inc., Cadila Pharmaceuticals Ltd, Dickinson and Company, Douglas Pharmaceuticals Ltd, ENT Technologies Pty. Ltd, Glaxosmithkline PLC, 3M United States, Merck & Co., Inc., Novartis AG, OptiNose, Inc, PendoPharm, Inc, Pfizer, Inc, Promius Pharma, LLC, Shin Nippon Biomedical Laboratories.
The nasal drug delivery technology market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nasal Drug Delivery Technology Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Nasal Drug Delivery Technology Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Nasal Drug Delivery Technology Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Nasal Drug Delivery Technology Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Nasal Drug Delivery Technology Market Size & Forecast, 2018-2028 4.5.1 Nasal Drug Delivery Technology Market Size and Y-o-Y Growth 4.5.2 Nasal Drug Delivery Technology Market Absolute $ Opportunity
Chapter 5 Global Nasal Drug Delivery Technology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nasal Drug Delivery Technology Market Size Forecast by Type
5.2.1 Pressurized Type
5.2.2 Non-pressurized Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nasal Drug Delivery Technology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nasal Drug Delivery Technology Market Size Forecast by Applications
6.2.1 Nasal Congestion
6.2.2 Rhinitis
6.2.3 Asthma
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nasal Drug Delivery Technology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nasal Drug Delivery Technology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nasal Drug Delivery Technology Analysis and Forecast
9.1 Introduction
9.2 North America Nasal Drug Delivery Technology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nasal Drug Delivery Technology Market Size Forecast by Type
9.6.1 Pressurized Type
9.6.2 Non-pressurized Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nasal Drug Delivery Technology Market Size Forecast by Applications
9.10.1 Nasal Congestion
9.10.2 Rhinitis
9.10.3 Asthma
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nasal Drug Delivery Technology Analysis and Forecast
10.1 Introduction
10.2 Europe Nasal Drug Delivery Technology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nasal Drug Delivery Technology Market Size Forecast by Type
10.6.1 Pressurized Type
10.6.2 Non-pressurized Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nasal Drug Delivery Technology Market Size Forecast by Applications
10.10.1 Nasal Congestion
10.10.2 Rhinitis
10.10.3 Asthma
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nasal Drug Delivery Technology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nasal Drug Delivery Technology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nasal Drug Delivery Technology Market Size Forecast by Type
11.6.1 Pressurized Type
11.6.2 Non-pressurized Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nasal Drug Delivery Technology Market Size Forecast by Applications
11.10.1 Nasal Congestion
11.10.2 Rhinitis
11.10.3 Asthma
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nasal Drug Delivery Technology Analysis and Forecast
12.1 Introduction
12.2 Latin America Nasal Drug Delivery Technology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nasal Drug Delivery Technology Market Size Forecast by Type
12.6.1 Pressurized Type
12.6.2 Non-pressurized Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nasal Drug Delivery Technology Market Size Forecast by Applications
12.10.1 Nasal Congestion
12.10.2 Rhinitis
12.10.3 Asthma
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nasal Drug Delivery Technology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nasal Drug Delivery Technology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nasal Drug Delivery Technology Market Size Forecast by Type
13.6.1 Pressurized Type
13.6.2 Non-pressurized Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nasal Drug Delivery Technology Market Size Forecast by Applications
13.10.1 Nasal Congestion
13.10.2 Rhinitis
13.10.3 Asthma
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nasal Drug Delivery Technology Market: Competitive Dashboard
14.2 Global Nasal Drug Delivery Technology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M United States
14.3.2 Aegis Therapeutics LLC
14.3.3 Aptargroup, Inc.
14.3.4 Becton, Dickinson and Company
14.3.5 BF Ascher & Company, Inc.
14.3.6 Cadila Pharmaceuticals Ltd
14.3.7 Dickinson and Company
14.3.8 Douglas Pharmaceuticals Ltd
14.3.9 ENT Technologies Pty. Ltd
14.3.10 Glaxosmithkline PLC
14.3.11 3M United States
14.3.12 Merck & Co., Inc.
14.3.13 Novartis AG
14.3.14 OptiNose, Inc
14.3.15 PendoPharm, Inc
14.3.16 Pfizer, Inc
14.3.17 Promius Pharma, LLC
14.3.18 Shin Nippon Biomedical Laboratories